Introduction
Despite careful hygiene and powerful broad-spectrum antibiotic treatment, neonatal septicemia remains an unsolved problem associated with high mortality [1] . Neonatal sepsis may be subdivided into early-onset neonatal sepsis (EONS) and late-onset neonatal sepsis (LONS). The former is caused by microorganisms acquired from the mother before or during birth, is vertically transmitted and perinatally acquired. LONS is infection presenting 4 or more days after birth and is generally caused by environmentally or nosocomially acquired microorganisms or by horizontal transmission, rather than from the mother [2] . Group B Streptococcus (GBS) is considered to be the most common microorganism causing EONS, but there have been reports of an increase in the incidence of early neonatal sepsis due to Escherichia coli, especially in premature or very low-birth-weight neonates [3, 4] . Stoll et al. [3] studied early onset neonatal sepsis from 1998 to 2000 and found a reduction in group B streptococcal sepsis (from 5.9 to 1.7 per 1,000 live births of very low-weight infants, p ! 0.001) and an increase in E. coli (from 3.2 to 6.8 per 1,000 live births, p = 0.004). The use of maternal intrapartum antibiotics for the prevention of GBS infection in the neonate is becoming increasingly common in developed countries [5] , but most of these antibiotics are administered in a term pregnancy. Maternal prophylactic antibiotics are also used in cases of preterm premature rupture of membranes and if chorioamnionitis is suspected [6] . Ampicillin and an aminoglycoside are the two antibiotics recommended for initial empiric therapy in the case of neonates with suspected bacterial sepsis and/ or meningitis [7, 8] , but may no longer be effective in treating many newborns with sepsis due to increased ampicillin resistance among EONS cases occurring in low-birth-weight and premature neonates [9] . Pathogens causing neonatal infections and their antimicrobial profiles may change over time and differ between countries [10] .
The objective of the present work was to evaluate the antimicrobial resistance of E. coli strains causing EONS and LONS as well as their evolution.
Materials and Methods

Bacteria
Sixty-one E. coli strains collected at the Hospital Clinic of Barcelona between 1995 and 2008 (27 from EONS and 34 from intrahospital LONS) were included in the study.
Antimicrobial Resistances
Minimal inhibitory concentrations were determined using the MicroScan-Negative MIC Panel Type 37 (NM37, Siemens). The antimicrobial agents tested were: amikacin (Ak), amoxicillin/K clavulanate (Aug), ampicillin (Am), ampicillin/sulbactam (A/S), aztreonam (Azt), cefazolin (Cfz), cefepime (Cpe), cefotaxime (Cft), cefotaxime/K clavulanate (Cft/CA), cefoxitin (Cfx), cefpodoxime (Cpd), ceftazidime (Caz), ceftazidime/K clavulanate (Caz/CA), cefuroxime (Crm), ciprofloxacin (Cp), chloramphenicol (C), colistin (Cl), ertapenem (Etp), fosfomycin (Fos), gentamicin (Gm), imipenem (Imp), levofloxacin (Lvx), meropenem (Mer), mezlocillin (Mz), moxifloxacin (Mxf), nitrofurantoin (Fd), norfloxacin (Nxn), piperacillin/tazobactam (P/T), piperacillin (Pi), tetracycline (Te), tigecycline (Tgc), tobramycin (To), and trimethoprim/sulfamethoxazole (T/S). The results were interpreted following CSLI guidelines [11] and E. coli ATCC25922 strain was used as the control.
Detection of Resistance Genes
We detected the following selected antimicrobial resistance genes: bla TEM1-like , bla OXA1-like , bla PSE1 in all ampicillin-resistant strains; bla CTX-M in ceftiofur-resistant strains; qnrA, B, C, D, S in all isolates; aac(3)-II, aac(3)-IV and aac(6)-Ib in gentamicin-resistant strains; catA , cmlA and floR in choramphenicol-resistant strains; dfrI -like, dfrA7-dfrA17 , dfrA12 , dfrA5-dfrA14 and dfrA17 in trimethroprim-resistant strains; sul1, sul2 and sul3 in sulfadiazine (Sd)-resistant strains, and tet(A), tet(B), tet(C), tet(D), tet(E) and tet(G) in tetracycline-resistant strains [12] [13] [14] [15] . Mutations in the quinolone resistance-determining region of the genes encoding the essential enzymes DNA gyrase and topoisomerase IV are the primary cause of clinically relevant levels of fluoroquinolone resistance in both gram-negative and gram-positive microorganisms [16] . Detection of these mutations and class 1 integrons were carried out by specific PCR amplification and sequencing as previously described [13] . The sequences obtained were compared to those registered in GenBank.
Statistical Analysis
Data were statistically analyzed using the Fisher exact test due to the small sample size.
Results
Among the E. coli strains causing EONS, 78% were collected from premature neonates (birth before 37 weeks of pregnancy and weighing less than 2.5 kg). All were born after prolonged premature membrane rupture and/ or chorioamnionitis. Antimicrobial resistance was tested in 61 E. coli strains collected from neonatal sepsis. No statistically significant differences were found between resistance profiles among strains causing EONS and those causing LONS. Strains from EONS tended to be more resistant to the ampicillin, mezlocillin and piperacillin ␤ -lactamics and to gentamicin than strains from LONS. On the other hand, strains causing LONS tended to be more resistant to chloramphenicol, moxifloxacin and tetracycline ( table 1 ) .
The evolution of the resistance was studied and, for this purpose, the E. coli strains causing neonatal sepsis, except those collected from infants 1 28 days of age, were divided into two groups depending on the year of isolation (1985-1999 and 2000-2008 ). An increase in the resistance to all the antimicrobial agents studied was observed in the second period of time. Moreover, the increase in resistance to gentamicin (0-26%), piperacillin (40-78%) and tobramycin (4-30%) between the two groups was statistically significant (p = 0.01, 0.01 and 0.02, respectively; fig. 1 ).
All ampicillin-resistant strains (42 isolates) were tested by PCR for the presence or absence of three different families of bla -genes. Bla TEM1 -like genes were found in 31 isolates (74% of the ampicillin-resistant strains). Of these, 19 (70%) were collected from EONS and only 16 (47%) were from LONS. The ␤ -lactam resistance phenotype of two strains (ampicillin-aztreonam-cefazolin-cefepimecefotaxime-cefpodoxime-ceftazidime-cefuroxime), one from EONS and the other from LONS, indicated the presence of extended-spectrum ␤ -lactamase enzymes. The bla CTX-M-15 gene was detected in the strain causing EONS and the bla CTX-M-14 gene was detected in the strain caus-ing LONS. In addition, one strain causing LONS presented the AmpC enzyme although it was not overexpressed ( table 2 ) .
The aac(3)-II gene was present in 75% (6/8) of the gentamicin-resistant strains, making it the most frequent among the two strain groups (EONS and LONS; table 2 ). Six determinants of tetracycline resistance were studied ( tetA, B, C, D, E and tetG ). The tetA gene was more frequently found among the strains from LONS (35%) than from EONS (11%). On the other hand, the tetB gene was more frequent among strains from EONS (19%) than from LONS (9%). The tetC and tetD genes were only found in two strains causing LONS. The tetE gene was found in one strain causing EONS, and the tetG gene was found in the same proportion of strains among the two groups ( table 2 ) .
Among the trimethoprim-resistant strains, the dfrA1 gene was the most frequently found (10 strains, 50%), followed by dfrA17 (3 strains) and dfrA12 (2 strains). No tetracycline resistance determinants were detected in 5 strains.
It is important to note the high percentage of strains that presented the sul-II gene (81%, 18 strains) among the sulfadiazine-resistant strains (22 strains), in contrast with the sul-I gene (7%, 2 strains from EONS) and sul-III (4%, 1 strain from EONS).
The quinolone resistance-determining regions of the gyrA and parC genes of all isolates were analyzed by PCR amplification/sequencing. All susceptible strains presented the same amino acid codons in both the gyrA and parC genes as the E. coli K12 strain MG1655 (GenBank accession numbers AE000312 and AE000384). The only Cp-resistant E. coli strain from EONS presented a single To determine the prevalence of class 1 integrons among the E. coli strains, all resistant strains were tested for the presence or absence of class 1 and class 2 integrons by PCR. Class 1 integrons were present in 13 strains. The analysis of the variable region of these integrons by PCR sequencing using the 5 CS/3 CS primers allowed four different integron types to be defined. Integrons generating amplicons of about 1,000 bp and carrying the aadA1 gene cassette were the most frequently found (5 strains: 3 from EONS and 2 from LONS), followed by integrons with variable regions of 700 bp, carrying dfrAIa (4 strains from LONS). Other integrons found had variable regions of 1,700 bp with dfrA17-aadA5 (2 strains from EONS) and 1,600 bp carrying dfrA1-aadA1a (2 strains from LONS).
Discussion
Neonatal sepsis is one of the most important causes of infant morbidity and mortality [17] . Bacterial neonatal sepsis remains a significant problem for pediatricians in spite of the prevention of EONS due to Streptococcus agalactiae by intrapartum antibiotic prophylaxis in developed countries such as Spain. In fact, these prophylactic policies, which were developed in the 1990s [18, 19] , have decreased the incidence of S. agalactiae infections ( 1 70% in perinatal invasive GBS disease incidence in the United States) [20] ; however, the role of Gram-negative bacteria in newborn infection has gained importance. E. coli is a significant cause of mortality among newborns, particularly among those of very low weight [3, 4] . There are few studies on the antimicrobial resistance of E. coli strains causing neonatal sepsis.
Ampicillin, gentamicin or cephalosporins are chosen as treatments in newborns with sepsis. In the present study a higher percentage of resistance to ampicillin and gentamicin among strains causing EONS was observed in comparison with those causing LONS. In addition, the percentages of resistance to all the antimicrobial agents studied have increased between 1985 and 2008. A possible explanation for these results may be the use of ampi- ) cillin and gentamicin in the treatment of premature preterm membrane rupture and chorioamnionitis, which has led to the selection of more resistant strains. Several studies have reported a relationship between intrapartum therapy and the presence of ampicillin-resistant E. coli in neonates. Joseph et al. [21] observed an increase in the proportion of infections caused by ampicillin-resistant E. coli in the period between 1988 and 1993 (67%) compared to the earlier period between 1982 and 1987 (25%) which was concomitant with the fact that in the second period 61% of the mothers received intrapartum ampicillin in contrast with the first period when only 17% received this therapy. Terrone et al. [22] , Bizarro et al. [17] and Kunh et al. [23] found a possible association between antenatal antibiotic treatment, prolonged antepartum exposure to ampicillin and infection with ampicillin-resistant E. coli . However, there are also several studies that have demonstrated that this relationship does not exist [20] . Friedman et al. [5] postulated that the presence of prolonged rupture of the fetal membranes and an elevated maternal temperature during labor, which is suggestive of chorioamnionitis, are also perinatal variables associated with the emergence of resistant E. coli isolates. In addition, a lower gestational age and birth weight are neonatal variables associated with the appearance of these resistant strains.
The percentage of ampicillin-resistant E. coli collected from neonates found in the present study is similar to that found in other studies. However, differences in the percentages of Gram-resistant isolates from 3% [3] to 50% [5, 24] among EONS strains and from 0% [19] to 16% [4] among LONS strains seem to be present among the different studies [3, 5, 17, 24] . Quinolone resistance is frequently associated with extended-spectrum cephalosporin resistance in Enterobacteriaceae [25] ; however, this association was not found in the present study.
Studies on resistance mechanisms among E. coli strains collected from neonatal sepsis are scarce. However, several studies about determinants of resistance among E. coli strains collected from children have been reported. Karami et al. [26, 27] studied the occurrence of phenotypic tetracycline and ampicillin resistance and the carriage of resistance genes in intestinal E. coli strains obtained from Swedish infants followed over their first year of life. They found that 12% of strains were resistant to tetracycline. In contrast with the present study, tet B was the resistance gene most frequently found followed by tet A and tet C. This group only found 12% of ampicillin resistance among the strains analyzed, with the bla TEM-1 resistance gene being the most frequently found demonstrating ampicillin resistance. This gene was also the most prevalent among our series.
In conclusion, despite the limitation of the study due to the small number of strains, the observation of an increase in ampicillin and gentamicin resistance makes a change in the treatment of neonates necessary. Cephalosporins are one of the antibiotics suggested taking into account the lower percentages of resistance to these antimicrobial agents, despite the recent appearance of E. coli strains with extended-spectrum ␤ -lactamase. The increase in E. coli ampicillin-and piperacillin-resistant strains causing neonatal sepsis could be due to the selection of resistant strains due to exposure to antibiotics. Further studies are needed to elucidate the role of intrapartum antibiotic prophylaxis in the emergence of resistant strains.
